Adverse Event Following Immunisation: Clinical Trials

5 trials for Adverse Event Following Immunisation, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed, 1 recruiting. 4 Phase 4, 1 Not applicable.

By phase and status

PhaseTrialsStatus
Phase 44Completed 3, Recruiting 1
Not applicable1Completed 1

Follow Adverse Event Following Immunisation: new trials by email Literature Review of Adverse Event Following Immunisation trials Research Report on Adverse Event Following Immunisation

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Safety of RSV Preventive Monoclonal Antibody
Respiratory Syncytial Virus (RSV) Preventive Monoclonal Antibody - Fever, Adverse Event Following Immunisation
Phase 4RecruitingDuke University5242025-10-022026-03-16
Comparing the Use of a Mobile App for Surveillance of Adverse Events Following Influenza Immunization to a Web-Based Platform
Mobile app - CanImmunize, Web based notification - Mobile Apps, Immunization
Not applicableCompletedThe Ottawa Hospital24082020-10-012023-04-03
Safety of RIV4 Versus IIV4 in Pregnant Women
Quadrivalent Recombinant Influenza Vaccine, Quadrivalent Inactivated Influenza Vaccine - Safety, Adverse Event Following Immunisation
Phase 4CompletedDuke University3842019-09-052023-01-11
Study on Immunization Schedule of Beijing Tiantan Biological's Measles-mumps-rubella(MMR) Vaccine
Measles, mumps and rubella Combined Vaccine, Live - Measles, Mumps
Phase 4CompletedCenters for Disease Control and Prevention, China8732016-03-012017-05-19
A Study to Evaluate the Safety and Immunogenicity of Oral Polio Vaccine Type 2 in Infants and Children
SABIN monovalent OPV2 - Adverse Event Following Immunisation
Phase 4CompletedFidec Corporation1642015-10-012020-08-14

Narrower conditions

Fever (1)  ·  Influenza, Human (1)  ·  Measles (1)  ·  Mumps (1)  ·  Rubella (1)

Broader conditions

Infections (2)  ·  RNA Virus Infections (2)  ·  Virus Diseases (2)  ·  Body Temperature Changes (1)  ·  Mononegavirales Infections (1)  ·  Morbillivirus Infections (1)  ·  Mouth Diseases (1)  ·  Orthomyxoviridae Infections (1)  ·  Paramyxoviridae Infections (1)  ·  Parotid Diseases (1)  ·  Parotitis (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Respiratory Tract Diseases (1)  ·  Respiratory Tract Infections (1)  ·  Rubivirus Infections (1)

Interventions

FluLaval (1)  ·  Influenza Vaccines (1)  ·  Long-Term Synaptic Depression (1)  ·  nirsevimab (1)

Sponsors

Duke University (2)  ·  Centers for Disease Control and Prevention, China (1)  ·  Fidec Corporation (1)  ·  The Ottawa Hospital (1)

Countries

United States (2)  ·  Canada (1)  ·  China (1)

Top investigators

Anne McCarthy (1)  ·  Geeta K Swamy, MD (1)  ·  Jiang Wu (1)  ·  Karen R Broder, MD (1)  ·  Michael J Smith, MD (1)  ·  Xavier M Saez-Llorens, MD (1)

Results publications

PMID 33308427, PMID 36332645, PMID 37155240, PMID 40318674